RE: Have faith in Suzy...the Goddess!29 May 2020 10:10
I understand where you are coming from iceman and agree....trust is what I'm referring to...anything else has to be earned ......that includes super woman status....In the words of Ronald Reagan....trust but verify...Best wishes. Freddie
Yes...valju...I will...just hope the new team will start delivering on some of the recommendations shareholders requested....as, for me, any reference to anything associated with the spiral of death deal is like a red rag to a bull....
Fit bio ....alpha blue....George and Satu....spiral of death....I'm confused but nasty memories have returned....I'm not suggesting there is a anything that will cause damage to the sp....as the damage was done at the time....someone please explain....is it an unearthed skeleton in the cupboard...with G&S stamped on it.... as biofit / alpha blue... has opened old wounds. Can someone knowledgeable calm me down.
Food morning to you too Valju. ...Yes, wouldn't it be nice if the Valirx scientific results commence driving future investment.....I'm really looking forward to the Val201 update... Exciting times ahead and a potential shock for anyone wishing to gain on a falsely anticipated retrace. Fingers crossed for a bear trap. Have a good day. Freddie
Your probably right with that particular collection of stocks...but as for Valirx I'm desperate to see an end to its perception as a pump and dump stock. For this to happen...credibility, thus respect for the management team has to be earned. Then and only then the actual value of the treatments be accurately realized, via sound irrefutable data...this has yet to be updated.. .no more bull****...but data scientists will agree on and accept...then Valirx will hopefully rise in sustained value.
Biorelate helps scientists solving the most difficult biomedical challenges of today. We do this by curating truths from existing knowledge, enabling smarter and faster research & development. Worth looking at their website....
I like the following... paragraph... Kevin has a background in improving translational science, Kevin has developed strong links to government, funding bodies and academia, and has contributed to a number of public sector advisory committees. Kevin currently has non-executive roles with Biorelate Limited, Syndermix SA and the British Neuroscience Association, and is Chief Executive Officer at Biotaspheric Limited.
London, UK., 27 May 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company announces that subject to the completion of the satisfactory background checks, it intends to appoint Dr Kevin Cox as a director of the Company in the position as Non-executive Chairman.
Kevin has over 25 years' experience in the life science industry, covering a wide range of sectors such as biomanufacturing, anti-infectives development, biomedical imaging, pathology, and clinical pharmacology. Serving as CEO of high growth biotechnology businesses, he has extensive experience in strategy, corporate development, M&A, financing and joint ventures.
Kevin has a background in improving translational science, Kevin has developed strong links to government, funding bodies and academia, and has contributed to a number of public sector advisory committees. Kevin currently has non-executive roles with Biorelate Limited, Syndermix SA and the British Neuroscience Association, and is Chief Executive Officer at Biotaspheric Limited.
A further announcement will made in due course.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.